Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 7.05% | 349.56 | 0.0% | $4455.02m | |
| BNTX | BioNTech SE | 5.96% | 294.92 | 0.0% | $826.74m | |
| NVAX | Novavax, Inc. | 0.59% | 135.35 | 79.4% | $781.84m | |
| AMGN | Amgen, Inc. | -0.77% | 207.63 | 1.4% | $532.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.67% | 576.20 | 2.7% | $465.16m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.79% | 6.26 | 0.7% | $437.60m | |
| CCXI | ChemoCentryx, Inc. | 1.16% | 34.97 | 2.9% | $417.40m | |
| GILD | Gilead Sciences, Inc. | 0.64% | 67.67 | 1.0% | $400.74m | |
| ILMN | Illumina, Inc. | 2.84% | 420.78 | 3.3% | $364.05m | |
| XLRN | Acceleron Pharma, Inc. | -0.10% | 173.78 | 5.3% | $349.33m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.80% | 184.99 | 1.9% | $279.73m | |
| BIIB | Biogen, Inc. | 1.94% | 269.94 | 1.8% | $264.88m | |
| OCGN | Ocugen, Inc. | 12.26% | 9.34 | 0.0% | $222.68m | |
| XENE | Xenon Pharmaceuticals, Inc. | -0.42% | 30.73 | 0.4% | $173.11m | |
| CRSP | CRISPR Therapeutics AG | 1.19% | 96.70 | 0.6% | $165.13m |
Company Profile
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.